-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HSV-1/HSV-2-IN-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2490468-31-8.gif)
| Category | Herpes simplex Virus (HSV) |
| CAS | 2490468-31-8 |
| Description | HSV-1/HSV-2-IN-1 (compound 7d) is a HSV-1 and HSV-2 inhibitor, with EC50s of 7.6, 7.6, 4, and 12 μM for HSV-1 (KOS), HSV-2(G), HSV-1 TK- KOS ACVr and vaccinia virus in human embryonic lung fibroblast cell cultures. |
Product Information
| Synonyms | HSV-1/HSV-2-IN-1|HY-149022|CS-0529898 |
| Molecular Weight | 410.39 |
| Molecular Formula | C18H14F4N4OS |
| Canonical SMILES | CCN1C2=C(C=C(C=C2)F)C(=C1O)N=NC(=S)NC3=CC=C(C=C3)C(F)(F)F |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 582 |
| Exact Mass | 410.08244490 |
| Target | HSV; Orthopoxvirus |
| XLogP3-AA | 5.2 |
